P
The startup operates a drug discovery platform that utilizes a diverse virtual compound library and computational screening to identify novel small molecule drugs targeting challenging biological entities. This approach aims to facilitate the development of next-generation therapeutics, including new antibacterial agents and cancer treatments.
Cambridge, United Kingdom
Updated 2 months ago
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup operates a drug discovery platform that utilizes a diverse virtual compound library and computational screening to identify novel small molecule drugs targeting challenging biological entities. This approach aims to facilitate the development of next-generation therapeutics, including new antibacterial agents and cancer treatments.